Cumberland Pharmaceuticals (CPIX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.18, -4.77% vs the prior close of $7.54.
- Volume 86.35K shares, 1.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CPIX slides 4.8% to $7.18. Closed at $7.18, -4.77% vs the prior close of $7.54. Day range $7.00–$7.58, opened at $7.47.
CPIX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CPIX slides 4.8% to $7.18
- Closed at $7.18, -4.77% vs the prior close of $7.54. Day range $7.00–$7.58, opened at $7.47.
- Volume was 86.35K shares, 1.6x its 50-day average of 54.25K.
- Price is -3.2% vs its 50-day average ($7.42) and +32.1% vs its 200-day average ($5.43).
- 52-week range $1.85–$9.28; today's close sits at 72% of that range, 22.6% below the 52-week high.
Oct 15, 2026 — CPIX rises 0.7% to $7.54, 3 up days in a row
- Closed at $7.54, +0.67% vs the prior close of $7.49. Day range $7.41–$7.80, opened at $7.49.
- Volume was 32.30K shares, 0.6x its 50-day average of 56.96K — lighter than usual.
- Price is +1.5% vs its 50-day average ($7.43) and +39.2% vs its 200-day average ($5.42).
- 52-week range $1.85–$9.28; today's close sits at 77% of that range, 18.7% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — CPIX jumps 4.5% to $7.49
- Closed at $7.49, +4.46% vs the prior close of $7.17. Day range $7.04–$7.69, opened at $7.04.
- Volume was 58.60K shares, 1.0x its 50-day average of 59.81K.
- Price is +0.9% vs its 50-day average ($7.43) and +38.7% vs its 200-day average ($5.40).
- 52-week range $1.85–$9.28; today's close sits at 76% of that range, 19.3% below the 52-week high.
Oct 13, 2026 — CPIX rises 2.4% to $7.17
- Closed at $7.17, +2.43% vs the prior close of $7.00. Day range $6.85–$7.26, opened at $7.05.
- Volume was 31.90K shares, 0.5x its 50-day average of 67.49K — lighter than usual.
- Price is -3.5% vs its 50-day average ($7.43) and +33.2% vs its 200-day average ($5.38).
- 52-week range $1.85–$9.28; today's close sits at 72% of that range, 22.7% below the 52-week high.
Oct 12, 2026 — CPIX dips 0.4% to $7.00
- Closed at $7.00, -0.43% vs the prior close of $7.03. Day range $6.67–$7.25, opened at $6.67.
- Volume was 11.50K shares, 0.2x its 50-day average of 69.46K — lighter than usual.
- Price is -5.8% vs its 50-day average ($7.43) and +30.4% vs its 200-day average ($5.37).
- 52-week range $1.85–$9.28; today's close sits at 69% of that range, 24.6% below the 52-week high.
Oct 9, 2026 — CPIX rises 0.7% to $7.03
- Closed at $7.03, +0.72% vs the prior close of $6.98. Day range $6.70–$7.14, opened at $6.88.
- Volume was 30.40K shares, 0.4x its 50-day average of 69.61K — lighter than usual.
- Price is -5.3% vs its 50-day average ($7.42) and +31.3% vs its 200-day average ($5.36).
- 52-week range $1.85–$9.28; today's close sits at 70% of that range, 24.2% below the 52-week high.
Oct 8, 2026 — CPIX rises 1.3% to $6.98
- Closed at $6.98, +1.31% vs the prior close of $6.89. Day range $6.31–$7.07, opened at $6.85.
- Volume was 50.30K shares, 0.7x its 50-day average of 69.61K.
- Price is -5.9% vs its 50-day average ($7.42) and +30.7% vs its 200-day average ($5.34).
- 52-week range $1.85–$9.28; today's close sits at 69% of that range, 24.8% below the 52-week high.
Oct 7, 2026 — CPIX slides 3.5% to $6.89
- Closed at $6.89, -3.50% vs the prior close of $7.14. Day range $6.85–$7.22, opened at $7.01.
- Volume was 24.60K shares, 0.3x its 50-day average of 71.59K — lighter than usual.
- Price is -7.0% vs its 50-day average ($7.41) and +29.3% vs its 200-day average ($5.33).
- 52-week range $1.85–$9.28; today's close sits at 68% of that range, 25.8% below the 52-week high.
Oct 6, 2026 — CPIX rises 0.7% to $7.14
- Closed at $7.14, +0.71% vs the prior close of $7.09. Day range $7.02–$7.28, opened at $7.06.
- Volume was 22.60K shares, 0.3x its 50-day average of 72.59K — lighter than usual.
- Price is -3.7% vs its 50-day average ($7.41) and +34.3% vs its 200-day average ($5.32).
- 52-week range $1.85–$9.28; today's close sits at 71% of that range, 23.1% below the 52-week high.
Oct 5, 2026 — CPIX slides 4.1% to $7.09, 3 down days in a row
- Closed at $7.09, -4.06% vs the prior close of $7.39. Day range $6.84–$7.35, opened at $7.35.
- Volume was 57.00K shares, 0.8x its 50-day average of 73.91K.
- Price is -4.3% vs its 50-day average ($7.41) and +33.8% vs its 200-day average ($5.30).
- 52-week range $1.85–$9.28; today's close sits at 71% of that range, 23.6% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — CPIX dips 1.6% to $7.39
- Closed at $7.39, -1.60% vs the prior close of $7.51. Day range $7.28–$7.74, opened at $7.57.
- Volume was 22.60K shares, 0.3x its 50-day average of 81.84K — lighter than usual.
- Price is -0.1% vs its 50-day average ($7.40) and +39.9% vs its 200-day average ($5.28).
- 52-week range $1.85–$9.28; today's close sits at 75% of that range, 20.4% below the 52-week high.
CPIX latest news & SEC filings
Every SEC filing by or about CPIX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 11, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.07 — Reported shareholder vote results.
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $8.80M (prior year $10.84M) (-18.8% vs Jun 30, 2025)
- Net income: -$4.28M (prior year -$740.74K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.29 (prior year -$0.05) (loss widened vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 1.02 — Ended a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 8.01 — Reported other events the company considers important.
Jun 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade CPIX
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 3, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.71% (largest 8.0%).
- Liquidity: about 41.33K shares (≈$296.77K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.18 vs a range of $1.85–$9.28 (72% of the range).
- Dividends: last ex-dividend date Aug 3, 2026 ($1.5/share); 1 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Aug 28, 2026; 10-Q Aug 7, 2026; 8-K Aug 4, 2026.
- Share count: 14.98M shares outstanding (Aug 5, 2026), +0.2% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CPIX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.47 | 7.58 | 7.00 | 7.18 | 86.35K |
| Oct 15, 2026 | 7.49 | 7.80 | 7.41 | 7.54 | 32.30K |
| Oct 14, 2026 | 7.04 | 7.69 | 7.04 | 7.49 | 58.60K |
| Oct 13, 2026 | 7.05 | 7.26 | 6.85 | 7.17 | 31.90K |
| Oct 12, 2026 | 6.67 | 7.25 | 6.67 | 7.00 | 11.50K |
| Oct 9, 2026 | 6.88 | 7.14 | 6.70 | 7.03 | 30.40K |
| Oct 8, 2026 | 6.85 | 7.07 | 6.31 | 6.98 | 50.30K |
| Oct 7, 2026 | 7.01 | 7.22 | 6.85 | 6.89 | 24.60K |
| Oct 6, 2026 | 7.06 | 7.28 | 7.02 | 7.14 | 22.60K |
| Oct 5, 2026 | 7.35 | 7.35 | 6.84 | 7.09 | 57.00K |
| Oct 2, 2026 | 7.57 | 7.74 | 7.28 | 7.39 | 22.60K |
| Oct 1, 2026 | 7.90 | 8.14 | 7.26 | 7.51 | 73.30K |
| Sep 30, 2026 | 7.75 | 8.04 | 7.61 | 7.83 | 10.00K |
| Sep 29, 2026 | 7.78 | 7.90 | 7.60 | 7.65 | 8.90K |
| Sep 28, 2026 | 7.61 | 7.87 | 7.56 | 7.72 | 30.30K |
| Sep 25, 2026 | 8.06 | 8.06 | 7.48 | 7.61 | 46.90K |
| Sep 24, 2026 | 7.93 | 8.29 | 7.75 | 8.01 | 48.80K |
| Sep 23, 2026 | 8.07 | 8.34 | 7.72 | 7.94 | 76.20K |
| Sep 22, 2026 | 7.50 | 8.35 | 7.50 | 8.20 | 70.50K |
| Sep 21, 2026 | 7.42 | 7.59 | 7.09 | 7.59 | 33.60K |
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals (CPIX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NASHVILLE,, TN. State of incorporation: TN. Fiscal year ends December 31. SEC CIK 1087294.
CPIX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Martin S Jr Brown | Director | Mar 20, 2026 |
| Joseph C Galante | Director | Mar 20, 2026 |
| James Jones | Director | Mar 20, 2026 |
| A J Kazimi | Chairman and CEO | Mar 20, 2026 |
| Kenneth Krogulski | Director | Mar 20, 2026 |
| Caroline Young | Director | Mar 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Todd M. Anthony | Vice Pres Organizational Dev | Mar 20, 2026 |
| Chris T. Bitterman | Vice Pres Sales & Marketing | Mar 20, 2026 |
| John M. Hamm | VP Chief Financial Officer | Mar 20, 2026 |
| James L Herman | VP and Chief Compliance Office | Mar 20, 2026 |
| A J Kazimi | Chairman and CEO | Mar 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CPIX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $44.52M | $-2.84M | -0.19 | $4.93M |
| Dec 31, 2024 | $37.87M | $-6.48M | -0.46 | $-612.19K |
| Dec 31, 2023 | $39.55M | $-6.28M | -0.44 | $6.09M |
| Dec 31, 2022 | $42.01M | $-5.57M | -0.38 | $8.45M |
| Dec 31, 2021 | $35.05M | $-3.51M | -0.24 | $6.34M |
Latest balance sheet: total assets $62.88M, total liabilities $45.77M, cash $3.86M (as of Jun 30, 2026).
CPIX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $7.77 |
| May 5, 2026 | 8-K Item 2.02 (results) | $4.55 |
| Mar 3, 2026 | 8-K Item 2.02 (results) | $4.58 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $2.66 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $3.79 |
| May 6, 2025 | 8-K Item 2.02 (results) | $4.41 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $6.05 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $1.20 |
| Aug 6, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CPIX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.